Neuro-Oncology Reviews
Volume
25 Number 24
31 December 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 24, 31 December
Mushtaq N, Ul Ain R, Hamid SA,
Bouffet E.
Evolution
of Systemic Therapy in Medulloblastoma Including
Irradiation-Sparing Approaches.
Diagnostics
(Basel). 2023 Dec 16;13(24):3680∟.
doi: 10.3390/diagnostics13243680∟.
PMID: 38132264∟.
Review. ˍ
Ackerstaff E, López-Larrubia
P.
Editorial:
Differentiating brain cancers and glioblastoma through imaging
methodologies.
Front
Oncol. 2023 Dec
18;13:1351874. doi:
10.3389/fonc.2023.1351874. PMID:
38164194. Editorial. ˍ
Farooq M, Scalia G, Umana GE,
Parekh UA, Naeem F, Abid SF, Khan MH, Zahra SG, Sarkar HP,
Chaurasia B.
A
Systematic Review of Nanomedicine in Glioblastoma Treatment:
Clinical Efficacy, Safety, and Future Directions.
Brain
Sci. 2023 Dec 18;13(12):1727∟.
doi: 10.3390/brainsci13121727∟.
PMID: 38137175∟.
Review. ˍ
No authors listed.
Correction
to: Lessons learned from phase 3 trials of immunotherapy for
glioblastoma: Time for longitudinal sampling?
Neuro
Oncol. 2023 Dec 18:noad241∟.
doi: 10.1093/neuonc/noad241∟.
PMID: 38109270∟.
Correction. ˍ
Refers to:
Chen
E, Ling AL, et al. Lessons
learned from phase 3 trials of immunotherapy for glioblastoma:
Time for longitudinal sampling?
Neuro
Oncol. 2023 Nov 23:noad211∟.
doi: 10.1093/neuonc/noad211∟.
PMID: 37995317∟.
Review. ˍ
Kosianova А, Pak O,
Bryukhovetskiy I.
Regulation
of cancer stem cells and immunotherapy of glioblastoma
(Review).
Biomed
Rep. 2023 Dec
19;20(2):24. doi:
10.3892/br.2023.1712. PMID:
38170016. Review. ˍ
Rechberger JS, Power EA, DeCuypere
M, Daniels DJ.
Evolution
of neurosurgical advances and nuances in medulloblastoma
therapy.
Childs
Nerv Syst. 2023 Dec 19∟.
doi: 10.1007/s00381-023-06239-x∟.
PMID: 38112693∟.
Review˰ ˍ
Xu S, Zhang G, Zhang J, Liu W, Wang
Y, Fu X.
Advances
in Brain Tumor Therapy Based on the Magnetic Nanoparticles.
Int
J Nanomedicine. 2023 Dec 20;18:7803-7823∟.
doi: 10.2147/IJN.S444319∟.
PMID: 38144513∟.
Review. ˍ
La Torre D, Della Torre A, Lo Turco
E, Longo P, Pugliese D, Lacroce P, Raudino G, Romano A, Lavano A,
Tomasello F.
Primary
Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma?
An Update of the Clinical, Radiological, and Biomolecular
Characteristics.
J
Clin Med. 2023
Dec 22;13(1):83. doi:
10.3390/jcm13010083. PMID:
38202090. Review. ˍ
Alfuridy G, Alghamdi R, Alkhoshi A,
Mahjari A, Alhussein A, Alshehri E, Lary A, Sabbagh A, Alomar
S.
Does
exogenous hormonal therapy affect the risk of glioma among
females: A systematic review and meta-analysis.
Neurooncol
Adv. 2023 Dec
23;6(1):vdad167. doi:
10.1093/noajnl/vdad167. PMID:
38405204. Review; Meta-analysis.
ˍ
Ramar V, Guo S, Hudson B, Liu
M.
Progress
in Glioma Stem Cell Research.
Cancers
(Basel). 2023 Dec 24;16(1):102.
doi:
10.3390/cancers16010102. PMID:
38201528. Review. ˍ
Shaghaghian E, Park DJ, Yoo KH,
Meola A, Chang SD.
CyberKnife
Radiosurgery for Extracranial Metastases of Oligodendroglioma: A
Clinical Case Report.
Cureus.
2023 Dec 24;15(12):e51035. doi:
10.7759/cureus.51035. PMID:
38264380. Case report, Review. ˍ
Mueller S, Fangusaro J, Thomas AO,
Jacques TS, Bandopadhayay P, de Blank P, Packer RJ, Fouladi M, van
Meeteren AS, Jones D, Perry A, Nakano Y, Hargrave D, Riedl D,
Robinson NJ, Partanen M, Fisher MJ, Witt O.
Consensus
framework for conducting phase I/II clinical trials for children,
adolescents, and young adults with pediatric low-grade glioma:
Guidelines established by the International Pediatric Low-Grade
Glioma Coalition Clinical Trial Working Group.
Neuro
Oncol. 2023 Dec 26:noad227∟.
doi: 10.1093/neuonc/noad227∟.
PMID: 38146999∟.
Guidelines. ˍ
Arora H, Mammi M, Patel NM, Zyfi D,
Dasari HR, Yunusa I, Simjian T, Smith TR, Mekary RA.
Dexamethasone
and overall survival and progression free survival in patients
with newly diagnosed glioblastoma: a meta-analysis.
J
Neurooncol. 2023 Dec 27∟.
doi: 10.1007/s11060-023-04549-3∟.
PMID: 38151699∟.
Meta-analysis˰ ˍ
Atallah O, Almealawy YF, Awuah WA,
Conti A, Chaurasia B.
Is
simultaneous occurrence of meningioma and glioblastoma a mere
coincidence?
Clin
Neurol Neurosurg.
2023 Dec 27;236:108099. doi:
10.1016/j.clineuro.2023.108099. PMID:
38215500. Review˰ ˍ
Malhotra K, Dagli MM, Gujral J, Santangelo G, Goyal K, Wathen C,
Ozturk AK, Welch WC.
Global and Gender
Equity in Oligodendroglioma Research: A Comprehensive Bibliometric
Analysis Following the COVID-19 Pandemic.
Cureus.
2023 Dec 27;15(12):e51161. doi:
10.7759/cureus.51161. PMID:
38283488. Bibliometric analysis. ˍ
Paterson C, Kavanagh PS, Bacon R,
Turner M, Moore M, Barratt M, Chau M.
To
understand the experiences, needs, and preferences for supportive
care, among children and adolescents (0-19 years) diagnosed with
cancer: a systematic review of qualitative studies.
J
Cancer Surviv. 2023 Dec 27∟.
doi: 10.1007/s11764-023-01508-9∟.
PMID: 38151586∟.
Review˰ ˍ
Kienzler JC, Fandino J.
The
Impact of Aspirin in Brain Tumor Surgery: To Stop or Not to
Stop?
Cureus.
2023 Dec 28;15(12):e51231. doi:
10.7759/cureus.51231. PMID:
38283531. Case report, Review. ˍ
Nikoobakht M, Shamshiripour P,
Mostafavi Zadeh SM, Rahnama M, Hajiahmadi F, Ramezani A, Farzam
Rad V, Nazari E, Moradi AR, Akbarpour M, Ahmadvand D.
Efficacy
of cell-based immunotherapies on patients with glioma: an umbrella
review of systematic reviews and meta-analysis protocol.
BMJ
Open. 2023 Dec 28;13(12):e072484∟. doi:
10.1136/bmjopen-2023-072484∟.
PMID: 38154889∟.
Review. ˍ
Godoy LFS, Paes VR, Ayres AS,
Bandeira GA, Moreno RA, Hirata FCC, Silva FAB, Nascimento F,
Campos Neto GC, Gentil AF, Lucato LT, Amaro Junior E, Young RJ,
Malheiros SMF.
Advances
in diffuse glial tumors diagnosis.
Arq
Neuropsiquiatr.
2023 Dec 29;81(12):1134-1145. doi:
10.1055/s-0043-1777729. PMID:
38157879. Review. ˍ
Sahebjam S, Leeper H.
Towards gender
equity in neuro-oncology.
Neurooncol
Pract. 2023 Dec 29;11(1):3-4. doi:
10.1093/nop/npad079. PMID:
38222051. Editorial˰ ˍ
Sanati M, Afshari AR, Ahmadi SS, Jamialahmadi T, Sahebkar
A.
Application of RNA-based
therapeutics in glioma: A review.
Prog
Mol Biol Transl Sci. 2023 Dec 29;204:133-161. doi:
10.1016/bs.pmbts.2023.12.001. PMID:
38458736. Review˰ ˍ